Want to join the conversation?
$ALB now expects 2016 net sales of $3.3-3.6Bil and adjusted EBITDA of $920-970MM. The company is raising its annual guidance given its strong 1Q performance, expectations for continued growth in most of its businesses and the April decision to keep its fine chemistry services business.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?